GT199800090A - Formas de dosificacion de solucion encapsulada de sertralina. - Google Patents

Formas de dosificacion de solucion encapsulada de sertralina.

Info

Publication number
GT199800090A
GT199800090A GT199800090A GT199800090A GT199800090A GT 199800090 A GT199800090 A GT 199800090A GT 199800090 A GT199800090 A GT 199800090A GT 199800090 A GT199800090 A GT 199800090A GT 199800090 A GT199800090 A GT 199800090A
Authority
GT
Guatemala
Prior art keywords
sertralina
dosage forms
encapsulated solution
encapsulated
dosage
Prior art date
Application number
GT199800090A
Other languages
English (en)
Inventor
William John Curatolo
Ravi Myosore Shanker
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT199800090(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT199800090A publication Critical patent/GT199800090A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

ESTA INVENCION SE REFIERE A UNA FORMA DE DOSIFICACION DE SOLUCION ENCAPSULADA DE SERTRALINA QUE PRESENTA, CON RESPECTO A LAS FORMAS DE DOSIFICACION DE LIBERACION INMEDIATA CONVENCIONALES, UN PERIODO DE TIEMPO MAS CORTO PARA ALCANZAR LOS NIVELES PICO EN SANGRE DESPUES DE LA DOSIFICACION ORAL, Y QUE TAMBIEN PRESENTA MENOS EFECTOS SECUNDARIOS.
GT199800090A 1997-07-01 1998-06-29 Formas de dosificacion de solucion encapsulada de sertralina. GT199800090A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5140197P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
GT199800090A true GT199800090A (es) 1999-12-21

Family

ID=21971076

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199800090A GT199800090A (es) 1997-07-01 1998-06-29 Formas de dosificacion de solucion encapsulada de sertralina.

Country Status (40)

Country Link
EP (1) EP0980241B1 (es)
JP (1) JP3585245B2 (es)
KR (1) KR100371730B1 (es)
CN (1) CN1261792A (es)
AP (1) AP945A (es)
AR (1) AR015916A1 (es)
AT (1) ATE256457T1 (es)
AU (1) AU724635B2 (es)
BG (1) BG103917A (es)
BR (1) BR9809712A (es)
CA (1) CA2290973C (es)
CO (1) CO4940405A1 (es)
DE (1) DE69820608T2 (es)
DK (1) DK0980241T3 (es)
DZ (1) DZ2544A1 (es)
EA (1) EA001905B1 (es)
ES (1) ES2210760T3 (es)
GT (1) GT199800090A (es)
HR (1) HRP980378B1 (es)
HU (1) HUP0002250A3 (es)
ID (1) ID24673A (es)
IL (1) IL133075A0 (es)
IS (1) IS5266A (es)
MA (1) MA24586A1 (es)
MY (1) MY119728A (es)
NO (1) NO996492L (es)
NZ (1) NZ501252A (es)
OA (1) OA11246A (es)
PA (1) PA8454001A1 (es)
PE (1) PE97299A1 (es)
PL (1) PL337807A1 (es)
PT (1) PT980241E (es)
SK (1) SK282914B6 (es)
TN (1) TNSN98123A1 (es)
TR (1) TR199903282T2 (es)
TW (1) TW382597B (es)
UA (1) UA68350C2 (es)
UY (1) UY25070A1 (es)
WO (1) WO1999001113A1 (es)
ZA (1) ZA985709B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2346335C (en) * 1998-10-13 2006-04-18 Pfizer Products Inc. Sertraline oral concentrate
US6727283B2 (en) 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
ES2393582T3 (es) 1999-09-03 2012-12-26 Apbi Holdings, Llc Procedimiento de utilización de inhibidores de la recaptación de serotonina selectivos de inicio rápido de acción para el tratamiento de las disfunciones sexuales
MXPA03001771A (es) 2000-08-30 2003-06-04 Pfizer Prod Inc Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento.
EP1375659A1 (en) * 2002-06-18 2004-01-02 Laboratorio di Diagnostica Moleculare Soluble capsules containing stock mixtures for easy preparation of chemical or biological solutions
AU2003291667A1 (en) * 2002-10-31 2004-06-07 Alza Corporation Pharmaceutical formulation providing an increased bioavailability of hydrophobic drugs
WO2016020936A2 (en) * 2014-07-21 2016-02-11 Patel Jayendrakumar Dasharathlal A novel oral gastroretentive pharmaceutical dosage form
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0782445B1 (en) * 1994-09-19 2002-03-13 Dupont Pharmaceuticals Company Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence
PT768083E (pt) * 1995-07-17 2003-08-29 Pfizer Sertralina para o tratamento de doentes pos-enfarte miocardico

Also Published As

Publication number Publication date
EP0980241A1 (en) 2000-02-23
KR20010013588A (ko) 2001-02-26
PA8454001A1 (es) 2000-05-24
TNSN98123A1 (fr) 2005-03-15
MY119728A (en) 2005-07-29
ZA985709B (en) 2000-01-10
MA24586A1 (fr) 1998-12-31
CA2290973C (en) 2003-06-17
ES2210760T3 (es) 2004-07-01
PE97299A1 (es) 1999-10-13
OA11246A (en) 2002-11-19
ID24673A (id) 2000-07-27
AP9801279A0 (en) 1998-06-30
SK180599A3 (en) 2001-01-18
DZ2544A1 (fr) 2003-02-08
TW382597B (en) 2000-02-21
UY25070A1 (es) 2000-12-29
UA68350C2 (en) 2004-08-16
SK282914B6 (sk) 2003-01-09
AR015916A1 (es) 2001-05-30
PT980241E (pt) 2004-03-31
CA2290973A1 (en) 1999-01-14
DE69820608D1 (de) 2004-01-29
AP945A (en) 2001-02-28
NO996492D0 (no) 1999-12-27
JP3585245B2 (ja) 2004-11-04
PL337807A1 (en) 2000-09-11
HRP980378A2 (en) 1999-04-30
NZ501252A (en) 2004-11-26
HRP980378B1 (en) 2001-12-31
AU7545098A (en) 1999-01-25
CN1261792A (zh) 2000-08-02
EP0980241B1 (en) 2003-12-17
TR199903282T2 (xx) 2000-08-21
EA199900963A1 (ru) 2000-08-28
WO1999001113A1 (en) 1999-01-14
IS5266A (is) 1999-11-23
EA001905B1 (ru) 2001-10-22
HUP0002250A3 (en) 2001-01-29
BR9809712A (pt) 2000-07-11
AU724635B2 (en) 2000-09-28
DK0980241T3 (da) 2004-04-05
ATE256457T1 (de) 2004-01-15
BG103917A (bg) 2000-07-31
HUP0002250A2 (hu) 2000-12-28
CO4940405A1 (es) 2000-07-24
NO996492L (no) 2000-02-29
KR100371730B1 (ko) 2003-02-07
JP2000512316A (ja) 2000-09-19
IL133075A0 (en) 2001-03-19
DE69820608T2 (de) 2004-12-23

Similar Documents

Publication Publication Date Title
TR199901077A2 (en) �spen�iyari form�lasyonlar.
AR040118A2 (es) Metodo para dispensar anteojos electroactivos
PA8484301A1 (es) Formulaciones farmaceuticas de liberacion controlada
HN1998000115A (es) Formas de dosificación farmacéuticas sólidas
PA8454401A1 (es) SALES DE SERTRALINA Y FORMAS DE DOSIFICACiON DE LIBERACION SOSTENIDA DE SERTRALINA
HN1998000132A (es) Combinaciones terapeuticas
HN1999000015A (es) Tratamiento para una disfuncion sexual femenina
AR028313A1 (es) Un procedimiento para la produccion de una composicion desodorante o antitranspirante
GT199800090A (es) Formas de dosificacion de solucion encapsulada de sertralina.
HN2001000278A (es) Procedimiento para la preparacion de imidazotriazininas substituidas con sulfonamida.
GT199800091A (es) Formas de dosificacion de sertralina de liberacion retardada.
AR028448A1 (es) Formulaciones que contienen una droga glucocorticoide para el tratamiento de enfermedades broncopulmonares
HN1998000167A (es) Nuevo procedimiento para preparar una cetoimina
ES2186989T3 (es) Cristales de maltitol de formas especificas, compuestos cristalinos que los contienen y procedimientos para su preparacion.
IS7539A (is) Sjálfskammtað getnaðarvarnarídælingarefni úr olíukenndri lausn.
DK1009406T3 (da) Farmaceutisk præparat til indgivelse af thiocolchicosid gennem mundslimhinden
ITTO20020105V0 (it) Dispositivo di personalizzazione per spazzolini da denti.
ES2188797T3 (es) Sales de n-(4-oxo-2-(1h-tetrazoil-5-il)-4h-1 benzopran-8-il)-4-(4-fenilbutoxi)benzamida.
ES1045742Y (es) Palo translucido para caramelos luminosos.
ES1047631Y (es) Dispositivo para la fabricacion de piezas modulares para la construccion.
KR960030397U (ko) 향기를 발산하는 양변기의 쿠션좌대
ES1039356Y (es) Bastidor monobloque para usos sanitarios.
ES1042068Y (es) Doble botin extraible para calzado.
ES1047378Y (es) Tercera luz de freno con ducha incorporada para la luna.
ES1044526Y (es) Dispositivo para la sujecion de los cordones del calzado.